PURPOSE: To develop novel positron emission tomography (PET) agents for visualization and therapy monitoring of bacterial infections. PROCEDURES: It is known that maltose and maltodextrins are energy sources for bacteria. Hence, (18)F-labelled maltose derivatives could be a valuable tool for imaging bacterial infections. We have developed methods to synthesize 4-O-(α-D-glucopyranosyl)-6-deoxy-6-[(18)F]fluoro-D-glucopyranoside (6-[(18)F]fluoromaltose) and 4-O-(α-D-glucopyranosyl)-1-deoxy-1-[(18)F]fluoro-D-glucopyranoside (1-[(18)F]fluoromaltose) as bacterial infection PET imaging agents. 6-[(18)F]fluoromaltose was prepared from precursor 1,2,3-tri-O-acetyl-4-O-(2',3',-di-O-acetyl-4',6'-benzylidene-α-D-glucopyranosyl)-6-deoxy-6-nosyl-D-glucopranoside (5). The synthesis involved the radio-fluorination of 5 followed by acidic and basic hydrolysis to give 6-[(18)F]fluoromaltose. In an analogous procedure, 1-[(18)F]fluoromaltose was synthesized from 2,3, 6-tri-O-acetyl-4-O-(2',3',4',6-tetra-O-acetyl-α-D-glucopyranosyl)-1-deoxy-1-O-triflyl-D-glucopranoside (9). Stability of 6-[(18)F]fluoromaltose in phosphate-buffered saline (PBS) and human and mouse serum at 37 °C was determined. Escherichia coli uptake of 6-[(18)F]fluoromaltose was examined. RESULTS: A reliable synthesis of 1- and 6-[(18)F]fluoromaltose has been accomplished with 4-6 and 5-8% radiochemical yields, respectively (decay-corrected with 95 % radiochemical purity). 6-[(18)F]fluoromaltose was sufficiently stable over the time span needed for PET studies (∼96% intact compound after 1-h and ∼65% after 2-h incubation in serum). Bacterial uptake experiments indicated that E. coli transports 6-[(18)F]fluoromaltose. Competition assays showed that the uptake of 6-[(18)F]fluoromaltose was completely blocked by co-incubation with 1 mM of the natural substrate maltose. CONCLUSION: We have successfully synthesized 1- and 6-[(18)F]fluoromaltose via direct fluorination of appropriate protected maltose precursors. Bacterial uptake experiments in E. coli and stability studies suggest a possible application of 6-[(18)F]fluoromaltose as a new PET imaging agent for visualization and monitoring of bacterial infections.
PURPOSE: To develop novel positron emission tomography (PET) agents for visualization and therapy monitoring of bacterial infections. PROCEDURES: It is known that maltose and maltodextrins are energy sources for bacteria. Hence, (18)F-labelled maltose derivatives could be a valuable tool for imaging bacterial infections. We have developed methods to synthesize 4-O-(α-D-glucopyranosyl)-6-deoxy-6-[(18)F]fluoro-D-glucopyranoside (6-[(18)F]fluoromaltose) and 4-O-(α-D-glucopyranosyl)-1-deoxy-1-[(18)F]fluoro-D-glucopyranoside (1-[(18)F]fluoromaltose) as bacterial infection PET imaging agents. 6-[(18)F]fluoromaltose was prepared from precursor 1,2,3-tri-O-acetyl-4-O-(2',3',-di-O-acetyl-4',6'-benzylidene-α-D-glucopyranosyl)-6-deoxy-6-nosyl-D-glucopranoside (5). The synthesis involved the radio-fluorination of 5 followed by acidic and basic hydrolysis to give 6-[(18)F]fluoromaltose. In an analogous procedure, 1-[(18)F]fluoromaltose was synthesized from 2,3, 6-tri-O-acetyl-4-O-(2',3',4',6-tetra-O-acetyl-α-D-glucopyranosyl)-1-deoxy-1-O-triflyl-D-glucopranoside (9). Stability of 6-[(18)F]fluoromaltose in phosphate-buffered saline (PBS) and human and mouse serum at 37 °C was determined. Escherichia coli uptake of 6-[(18)F]fluoromaltose was examined. RESULTS: A reliable synthesis of 1- and 6-[(18)F]fluoromaltose has been accomplished with 4-6 and 5-8% radiochemical yields, respectively (decay-corrected with 95 % radiochemical purity). 6-[(18)F]fluoromaltose was sufficiently stable over the time span needed for PET studies (∼96% intact compound after 1-h and ∼65% after 2-h incubation in serum). Bacterial uptake experiments indicated that E. coli transports 6-[(18)F]fluoromaltose. Competition assays showed that the uptake of 6-[(18)F]fluoromaltose was completely blocked by co-incubation with 1 mM of the natural substrate maltose. CONCLUSION: We have successfully synthesized 1- and 6-[(18)F]fluoromaltose via direct fluorination of appropriate protected maltose precursors. Bacterial uptake experiments in E. coli and stability studies suggest a possible application of 6-[(18)F]fluoromaltose as a new PET imaging agent for visualization and monitoring of bacterial infections.
Authors: Todd A Sasser; Ashley E Van Avermaete; Alexander White; Sarah Chapman; James R Johnson; Tony Van Avermaete; Seth T Gammon; W Matthew Leevy Journal: Curr Top Med Chem Date: 2013 Impact factor: 3.295
Authors: Oliver Langer; Martin Brunner; Markus Zeitlinger; Sophie Ziegler; Ulrich Müller; Georg Dobrozemsky; Edith Lackner; Christian Joukhadar; Markus Mitterhauser; Wolfgang Wadsak; Erich Minar; Robert Dudczak; Kurt Kletter; Markus Müller Journal: Eur J Nucl Med Mol Imaging Date: 2004-09-04 Impact factor: 9.236
Authors: Gayatri Gowrishankar; Jonathan Hardy; Mirwais Wardak; Mohammad Namavari; Robert E Reeves; Evgenios Neofytou; Ananth Srinivasan; Joseph C Wu; Christopher H Contag; Sanjiv Sam Gambhir Journal: J Nucl Med Date: 2017-05-10 Impact factor: 10.057
Authors: Matthew F L Parker; Robert R Flavell; Justin M Luu; Oren S Rosenberg; Michael A Ohliger; David M Wilson Journal: ACS Infect Dis Date: 2020-06-09 Impact factor: 5.084
Authors: Christopher A Mutch; Alvaro A Ordonez; Hecong Qin; Matthew Parker; Lauren E Bambarger; Javier E Villanueva-Meyer; Joseph Blecha; Valerie Carroll; Celine Taglang; Robert Flavell; Renuka Sriram; Henry VanBrocklin; Oren Rosenberg; Michael A Ohliger; Sanjay K Jain; Kiel D Neumann; David M Wilson Journal: ACS Infect Dis Date: 2018-05-08 Impact factor: 5.084
Authors: Colin W K Rosman; Francisco Romero Pastrana; Girbe Buist; Marjolein Heuker; Marleen van Oosten; James O McNamara; Gooitzen M van Dam; Jan Maarten van Dijl Journal: Sci Rep Date: 2018-01-22 Impact factor: 4.379
Authors: Kiel D Neumann; Javier E Villanueva-Meyer; Christopher A Mutch; Robert R Flavell; Joseph E Blecha; Tiffany Kwak; Renuka Sriram; Henry F VanBrocklin; Oren S Rosenberg; Michael A Ohliger; David M Wilson Journal: Sci Rep Date: 2017-08-11 Impact factor: 4.379
Authors: Thomas Ebenhan; Botshelo Brenda Mokaleng; Jacobus Daniel Venter; Hendrik Gert Kruger; Jan Rijn Zeevaart; Mike Sathekge Journal: Molecules Date: 2017-08-24 Impact factor: 4.411
Authors: Gayatri Gowrishankar; Mohammad Namavari; Erwan Benjamin Jouannot; Aileen Hoehne; Robert Reeves; Jonathan Hardy; Sanjiv Sam Gambhir Journal: PLoS One Date: 2014-09-22 Impact factor: 3.240